NCT05880537View on ClinicalTrials.gov

Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 6, 2023

Primary Completion Date

December 15, 2027

Study Completion Date

December 15, 2027

Conditions
End-Stage Renal Disease
Interventions
OTHER

Nexeon Arterial Venous Allograft

Nexeon AVX allograft for hemodialysis access in end stage renal disease

Trial Locations (4)

23507

RECRUITING

Sentara Norfolk General Hospital, Norfolk

36607

RECRUITING

Infirmary Heath, Mobile

90502

RECRUITING

Harbor-UCLA Medical Center, Torrance

91342

RECRUITING

Olive View - UCLA Medical Center, Sylmar

Sponsors

Lead Sponsor

LifeNet Health
All Listed Sponsors
lead

LifeNet Health

INDUSTRY

NCT05880537 - Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry | Biotech Hunter | Biotech Hunter